PuSH - Publication Server of Helmholtz Zentrum München

Cornberg, M.* ; Sandmann, L.* ; Protzer, U. ; Niederau, C.* ; Tacke, F.* ; Berg, T.* ; Glebe, D.* ; Jilg, W.* ; Wedemeyer, H.* ; Wirth, S.* ; Siederdissen, C.H.Z.* ; Lynen-Jansen, P.* ; Leeuwen, P.* ; Petersen, J.*

S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion.

Z. Gastroenterol. 59, 691-776 (2021)
DOI PMC
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.000
0.703
6
14
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Tenofovir Disoproxil Fumarate; Stem-cell Transplantation; E-antigen Seroconversion; Nucleos(t)ide Analog Therapy; Hbeag-negative Patients; Chronic Delta-hepatitis; Chronic Liver-disease; Persistently Normal Alt; Hbsag-positive Donors; Health-care Workers
Language german
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 0044-2739
e-ISSN 1439-7803
Quellenangaben Volume: 59, Issue: 7, Pages: 691-776 Article Number: , Supplement: ,
Publisher Thieme
Publishing Place Rudigerstr 14, D-70469 Stuttgart, Germany
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-502700-003
Scopus ID 85110740590
PubMed ID 34255317
Erfassungsdatum 2021-08-02